EDGAR Filing Documents for 0001104659-13-004773

Form 8-K - Current report:

SEC Accession No. 0001104659-13-004773

Filing Date

2013-01-25

Accepted

2013-01-25 17:28:53

Documents

Period of Report

2013-01-24

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a12-25051_98k.htm	8-K	28164
2	EX-4.4	a12-25051_9ex4d1.htm	EX-4.1	895788
3	EX-99.1	a12-25051_9ex99d1.htm	EX-99.1	10641
4	GRAPHIC	g250519mmi001.jpg	GRAPHIC	5115
5	GRAPHIC	g250519kg09i001.jpg	GRAPHIC	1640
6	GRAPHIC	g250519kg09i002.jpg	GRAPHIC	2099
7	GRAPHIC	g250519kg09i003.jpg	GRAPHIC	2104
8	GRAPHIC	g250519kg09i004.jpg	GRAPHIC	2327
9	GRAPHIC	g250519kg09i005.jpg	GRAPHIC	1957
10	GRAPHIC	g250519kg09i006.jpg	GRAPHIC	2964
	Complete submission text file	0001104659-13-004773.txt		962096

Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080

Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000

THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)